NKGen Biotech, Inc. (NKGN)
NASDAQ: NKGN · Real-Time Price · USD
0.640
+0.075 (13.25%)
Dec 20, 2024, 4:00 PM EST - Market closed
NKGen Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 23 | 60 | - | - |
| Enterprise Value | 51 | 71 | - | - |
| Last Close Price | 0.64 | 2.75 | 9.95 | 9.69 |
| PB Ratio | -0.45 | -1.03 | - | - |
| Debt / Equity Ratio | -0.40 | -0.34 | 7.70 | -1.37 |
| Asset Turnover | - | - | 0.00 | - |
| Quick Ratio | 0.00 | 0.00 | 0.01 | 0.01 |
| Current Ratio | 0.02 | 0.05 | 0.02 | 0.01 |
| Return on Assets (ROA) | -106.84% | -113.32% | -88.47% | - |
| Return on Capital (ROIC) | - | - | -110.60% | - |
| Earnings Yield | -382.86% | -137.81% | - | - |
| FCF Yield | -93.43% | -36.46% | - | - |
| Buyback Yield / Dilution | -250.53% | -142.70% | 55.39% | - |
| Total Shareholder Return | -250.53% | -142.70% | 55.39% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.